4-hydroxyifosfamide has been researched along with mesna in 2 studies
| Studies (4-hydroxyifosfamide) | Trials (4-hydroxyifosfamide) | Recent Studies (post-2010) (4-hydroxyifosfamide) | Studies (mesna) | Trials (mesna) | Recent Studies (post-2010) (mesna) |
|---|---|---|---|---|---|
| 27 | 5 | 4 | 1,235 | 251 | 205 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allenbacher, A; Botzler, C; Issels, RD; Meier, T; Multhoff, G; Wiesnet, M; Wilmanns, W | 1 |
| Kurowski, V; Wagner, T | 1 |
1 trial(s) available for 4-hydroxyifosfamide and mesna
| Article | Year |
|---|---|
Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged | 1997 |
1 other study(ies) available for 4-hydroxyifosfamide and mesna
| Article | Year |
|---|---|
Differential effects of ifosfamide on the capacity of cytotoxic T lymphocytes and natural killer cells to lyse their target cells correlate with intracellular glutathione levels.
Topics: Antibodies, Monoclonal; Antigens, CD; Buthionine Sulfoximine; CD3 Complex; Cells, Cultured; Cytotoxicity, Immunologic; Glutathione; Humans; Ifosfamide; Interleukin-2; Intracellular Fluid; Killer Cells, Natural; Lymphocyte Activation; Mesna; Methionine Sulfoximine; T-Lymphocytes, Cytotoxic | 1995 |